Already at best price
Mpride V1 Tablet SR
Glimepiride (1mg) + Voglibose (0.2mg) + Metformin (500mg)
Ajanta Pharma Ltd
Anti-Diabetic
₹210.94
1
Safe & Secure
Easy Returns
24/7 Support
Delivery
₹210.94
Active composition
Glimepiride 1 mg
+2 more active ingredients
How It Works
Glimepiride stimulates insulin secretion from pancreatic beta cells and enhances insulin sensitivity in peripheral tissues, facilitating glucose uptake and lowering blood sugar levels.
Voglibose inhibits intestinal alpha-glucosidases, delaying carbohydrate digestion and absorption, thus lowering postprandial glucose levels.
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
Medicine Strength
1 mg
All Active Ingredients
Glimepiride1 mg
Voglibose0.2 mg
Metformin500 mg
Uses & Benefits
Medical applications
Diabetes
Mpride V1 Tablet SR is a combined antidiabetic medication, containing Glimepiride 1mg, Metformin 500mg, and Voglibose 0.2mg. This triple therapy medication is designed for the treatment of type 2 diabetes mellitus. Glimepiride, a sulfonylurea, stimulates insulin secretion, while Metformin decreases glucose production in the liver and improves insulin sensitivity. Voglibose, an alpha-glucosidase inhibitor, delays carbohydrate absorption in the small intestine. By combining these three active ingredients, Mpride V1 Tablet SR aims to provide effective blood glucose control, improve glycemic stability, and reduce the risk of diabetes-related complications. As with any medication, it should be used under medical supervision and the potential for adverse effects should be considered.
Dosage & How to Use
How to use Mpride V Tablet SR Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Mpride V1 Tablet SR is to be taken with food.
Safety Advice
Important precautions
Side Effect Occurrence
Based on clinical trials and patient reports.
Overall Tolerance
Most patients tolerate well
✓Only 2.3% reported effects
Common Side Effects
Headache8%
Nausea5%
Higher
Lower
Safety Advice
Alcohol
It is unsafe to consume alcohol with Mpride V1 Tablet SR.
High Risk
Pregnancy
Mpride V1 Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Medical Advice
Driving
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Exercise Caution
Liver
Mpride V1 Tablet SR should be used with caution in patients with liver disease. Dose adjustment of Mpride V1 Tablet SR may be needed. Please consult your doctor. Mpride V1 Tablet SR is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.
Regular Checkup
Breastfeeding
Mpride V1 Tablet SR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Consult Doctor
Kidney
Mpride V1 Tablet SR is probably unsafe to use in patients with kidney disease and should be avoided. Please consult your doctor. Use of Mpride V1 Tablet SR is, however, not recommended in patients with severe kidney disease.
Regular Checkup
Customer Reviews
0 reviews for Mpride V1 Tablet SR
Mpride V1 Tablet SR
1 / 2
Rx RequiredSchedule H
Mpride V1 Tablet SR
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
₹210.94
1
Safe & Secure
Easy Returns
24/7 Support
Delivery
Cheaper alternative availability
Not Foundfor this medicine
Already at the Best Price
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
Glimepiride 1 mg
+2 more active ingredients
How It Works
Glimepiride stimulates insulin secretion from pancreatic beta cells and enhances insulin sensitivity in peripheral tissues, facilitating glucose uptake and lowering blood sugar levels.
Voglibose inhibits intestinal alpha-glucosidases, delaying carbohydrate digestion and absorption, thus lowering postprandial glucose levels.
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
Medicine Strength
1 mg
All Active Ingredients
Glimepiride1 mg
Voglibose0.2 mg
Metformin500 mg
Uses & Benefits
Medical applications
Diabetes
Mpride V1 Tablet SR is a combined antidiabetic medication, containing Glimepiride 1mg, Metformin 500mg, and Voglibose 0.2mg. This triple therapy medication is designed for the treatment of type 2 diabetes mellitus. Glimepiride, a sulfonylurea, stimulates insulin secretion, while Metformin decreases glucose production in the liver and improves insulin sensitivity. Voglibose, an alpha-glucosidase inhibitor, delays carbohydrate absorption in the small intestine. By combining these three active ingredients, Mpride V1 Tablet SR aims to provide effective blood glucose control, improve glycemic stability, and reduce the risk of diabetes-related complications. As with any medication, it should be used under medical supervision and the potential for adverse effects should be considered.
Dosage & How to Use
How to use Mpride V Tablet SR Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Mpride V1 Tablet SR is to be taken with food.
Safety Advice
Important precautions
Side Effect Occurrence
Based on clinical trials and patient reports.
Overall Tolerance
Most patients tolerate well
✓Only 2.3% reported effects
Common Side Effects
Headache8%
Nausea5%
Higher
Lower
Safety Advice
Alcohol
It is unsafe to consume alcohol with Mpride V1 Tablet SR.
High Risk
Pregnancy
Mpride V1 Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Medical Advice
Driving
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Exercise Caution
Liver
Mpride V1 Tablet SR should be used with caution in patients with liver disease. Dose adjustment of Mpride V1 Tablet SR may be needed. Please consult your doctor. Mpride V1 Tablet SR is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.
Regular Checkup
Breastfeeding
Mpride V1 Tablet SR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Consult Doctor
Kidney
Mpride V1 Tablet SR is probably unsafe to use in patients with kidney disease and should be avoided. Please consult your doctor. Use of Mpride V1 Tablet SR is, however, not recommended in patients with severe kidney disease.
Regular Checkup
Customer Reviews
0 reviews for Mpride V1 Tablet SR
%22%2F%3E%0A%3Ctext%20x%3D%22150%22%20y%3D%22158%22%20font-family%3D%22system-ui%2C-apple-system%2CSegoe%20UI%2CRoboto%2Csans-serif%22%20font-size%3D%2244%22%20font-weight%3D%22800%22%20text-anchor%3D%22middle%22%20fill%3D%22%23ffffff%22%20opacity%3D%220.45%22%20transform%3D%22rotate(-16%20150%20158)%22%3EDrugIndia%3C%2Ftext%3E%0A%3Cg%20fill%3D%22%23fb7185%22%20opacity%3D%220.5%22%3E%3Cpath%20d%3D%22M44%2048h6v6h6v6h-6v6h-6v-6h-6v-6h6z%22%2F%3E%3Cpath%20d%3D%22M250%20214h5v5h5v5h-5v5h-5v-5h-5v-5h5z%22%2F%3E%3C%2Fg%3E%0A%3Cellipse%20cx%3D%22150%22%20cy%3D%22120%22%20rx%3D%22118%22%20ry%3D%2286%22%20fill%3D%22url(%23glow)%22%2F%3E%0A%3Cg%20transform%3D%22rotate(-28%20150%20120)%22%20filter%3D%22url(%23soft)%22%20font-family%3D%22system-ui%2C-apple-system%2CSegoe%20UI%2CRoboto%2Csans-serif%22%3E%0A%3Crect%20x%3D%2289%22%20y%3D%2297%22%20width%3D%22122%22%20height%3D%2246%22%20rx%3D%2223%22%20fill%3D%22url(%23cap)%22%2F%3E%0A%3Cpath%20d%3D%22M89%20120a23%2023%200%200%201%2023-23h38v46h-38a23%2023%200%200%201-23-23z%22%20fill%3D%22%23ffffff%22%20opacity%3D%220.16%22%2F%3E%0A%3Cline%20x1%3D%22150%22%20y1%3D%2298%22%20x2%3D%22150%22%20y2%3D%22142%22%20stroke%3D%22%23ffffff%22%20stroke-width%3D%222%22%20opacity%3D%220.55%22%2F%3E%0A%3Cellipse%20cx%3D%22118%22%20cy%3D%22110%22%20rx%3D%2215%22%20ry%3D%225%22%20fill%3D%22%23ffffff%22%20opacity%3D%220.4%22%2F%3E%0A%3C%2Fg%3E%0A%3Ctext%20x%3D%22150%22%20y%3D%22206%22%20font-size%3D%2222%22%20font-weight%3D%22700%22%20letter-spacing%3D%220.2%22%20text-anchor%3D%22middle%22%20fill%3D%22%237c2d12%22%3ESITARAY%20M%3C%2Ftext%3E%3Ctext%20x%3D%22150%22%20y%3D%22232%22%20font-size%3D%2222%22%20font-weight%3D%22700%22%20letter-spacing%3D%220.2%22%20text-anchor%3D%22middle%22%20fill%3D%22%237c2d12%22%3E50%2F500MG%20TAB%3C%2Ftext%3E%0A%3Cg%20font-family%3D%22system-ui%2C-apple-system%2CSegoe%20UI%2CRoboto%2Csans-serif%22%3E%0A%3Ctext%20x%3D%22150%22%20y%3D%22271%22%20font-size%3D%2215%22%20font-weight%3D%22800%22%20letter-spacing%3D%221.5%22%20text-anchor%3D%22middle%22%20fill%3D%22%23ffffff%22%20opacity%3D%220.85%22%3EDRUGINDIA%3C%2Ftext%3E%0A%3Ctext%20x%3D%22150%22%20y%3D%22270%22%20font-size%3D%2215%22%20font-weight%3D%22800%22%20letter-spacing%3D%221.5%22%20text-anchor%3D%22middle%22%20fill%3D%22%23c2410c%22%3EDRUGINDIA%3C%2Ftext%3E%0A%3C%2Fg%3E%0A%3C%2Fsvg%3E)